Overview
MS Nursing Care: Case Presentations From the 2019 Linda Morgante Program
Click the"View Activity" button to view this activity.
View ActivityCME/CE is no longer available for this activity
This enduring activity features two MS cases presented at the 11th Annual Linda Morgante MS Nurse Leadership Program in Seattle, Washington in May 2019. The cases, encompassing both treatment considerations and symptom management, provide key insights to improving patient outcomes from the nursing perspective. For additional MS nursing education, topics from last year’s program can be accessed in the player or by visiting: http://www.achlcme.org/lindamorgante2018
This activity is intended for early career nurses and advanced career nurses with a stated interest in MS.
The goal of the enduring activity is to provide nurses in MS with the opportunity to listen to the hot topics addressed during the 11th Annual Linda Morgante MS Nurse Leadership Program that took place in Seattle, Washington in May 2019.
Upon completion of this activity, participants will be able to:
-Improve patient outcomes by identifying, assessing, and managing emerging MS-related symptoms and DMT-related adverse events.
-Discuss the goals of MS treatment with patients to encourage adherence to treatment.
-Apply evidence-based diagnostic and assessment approaches for evaluating disease activity in the brain and spinal cord to develop individualized treatment plans in patients with MS.
-Illustrate how to facilitate coordination of care to ensure comprehensive MS treatment.
Sponsored by the Academy for Continued Healthcare Learning, Annenberg Center for Health Sciences at Eisenhower, and the International Organization of Multiple Sclerosis Nurses.
The mission of the International Organization of Multiple Sclerosis Nurses is to sustain and grow the specialty of MS nursing throughout the world.
The mission of the International Organization of Multiple Sclerosis Nurses is to sustain and grow the specialty of MS nursing throughout the world.
Colleen Harris, MN, NP (Chair)
Nurse Practitioner
University of Calgary MS Clinic
Calgary, Alberta, Canada
Nurse Practitioner
University of Calgary MS Clinic
Calgary, Alberta, Canada
Amy Perrin Ross, MSN (Chair)
Neuroscience Program Coordinator
Loyola University Medical Center
Maywood, Illinois
Michelle Keating, RN, MSCN
MS Nurse Consultant
St. Louis, Missouri
Beverly Layton, RN, CCRC, MSCN
MS Nurse Consultant
Birmingham, Alabama
Annenberg Center and ACHL requires that the faculty participating in a CE activity disclose all affiliations or other financial relationships (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. All conflicts of interest have been resolved prior to this CE activity.
The following financial relationships have been provided:
Colleen Harris, MN, NP (Chair)
Consulting Agreements: Biogen; EMD Serono; Genzyme; Roche
Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: None
Amy Perrin Ross, MSN (Chair)
Consulting Agreements: Biogen; Celgene; EMD Serono; Genentech; Genzyme; Merck; Novartis; Roche; Serono; TEVA; TG Therapeutics
Speakers’ Bureau: Biogen; EMD Serono; Genentech; Genzyme; Novartis;TEVA
Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: None
Michelle Keating, RN, MSCN
Has no relevant financial relationships to disclose, and will not be discussing off-label, investigational, or experimental drug use.
Beverly Layton, RN, CCRC, MSCN
Speakers' Bureau: Biogen; Genentech; Sanofi Genzyme
Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: None
ACHL and Annenberg Center staff members and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.
The content for this activity was developed independently of the commercial supporters. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher or grantors.
This educational activity was planned and produced in accordance with the policies of the ANCC Accreditation Program. Recommendations involving clinical medicine in a continuing medical education (CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.
This CE activity might describe the off-label, investigational, or experimental use of medications and/or devices that may exceed their FDA-approved labeling. Clinicians should consult the current manufacturers’ prescribing information for these products. Annenberg and ACHL require the speaker to disclose that a product is not labeled for the use under discussion.
In this activity, the following investigational/experimental uses are discussed: None.
In this activity, the following investigational/experimental uses are discussed: None.
This activity will take approximately 60 minutes to complete. To receive credit, participants are required to complete the pretest, view the online activity and complete the posttest and evaluation. To receive credit, 75% must be achieved on the posttest. A certificate will be immediately available. There is no fee to participate in the activity or for the generation of the certificate.
Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
A maximum of 1.00 contact hours may be earned for successful completion of this activity.
It is the policy of the Annenberg Center to ensure fair balance, independence, objectivity, and scientific rigor in all programming. All faculty and planners participating in sponsored programs are expected to identify and reference off-label product use and disclose any significant relationship with those supporting the activity or any others whose products or services are discussed.